• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVOCURE GMBH OPTUNE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVOCURE GMBH OPTUNE Back to Search Results
Model Number TFH9100
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Post Operative Wound Infection (2446)
Event Date 10/10/2023
Event Type  Injury  
Manufacturer Narrative
Novocure' s opinion is that a contribution of the array placement to the wound infection cannot be ruled out.Wound infection is an expected event with device use and was reported as an adverse event in the ef-14 trial of optune together with temozolomide (tmz) compared to tmz alone in patients with newly diagnosed gbm in both arms of the trial (<1% and <1% in optune/tmz and tmz arms respectively).
 
Event Description
A 58-year-old female with newly diagnosed glioblastoma (gbm) started optune therapy on (b)(6), 2023.On (b)(6), 2023, novocure was informed that the patient experienced a headache for approximately three days and optune therapy was temporarily discontinued.During an appointment at the hospital, it was discovered the patient's surgical wound was infected which resulted in hospital admission for surgery.On (b)(6), 2023, the patient's spouse confirmed that the patient underwent a craniotomy on (b)(6), 2023, due to a wound infection.The physician reported on (b)(6), 2023, that the patient experienced itching at the surgical resection site in (b)(6) 2023.It was noted the patient scratched the wound which resulted in the area becoming infected.The craniotomy conducted on (b)(6), 2023, consisted of removal of bone fragment, epidural abscess, and staphylococcus aureus was detected.The physician assessed that optune therapy contributed to the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTUNE
Type of Device
OPTUNE
Manufacturer (Section D)
NOVOCURE GMBH
business village d4
park 6/platz 10
root d4, 6039
SZ  6039
Manufacturer (Section G)
NOVOCURE GMBH
business village d4
park 6/platz 10
root d4, 6039
SZ   6039
Manufacturer Contact
sharon perez
195 commerce way
portsmouth, NH 03801
2077527602
MDR Report Key18082782
MDR Text Key327476738
Report Number3010457505-2023-00249
Device Sequence Number1
Product Code NZK
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/07/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberTFH9100
Device Catalogue NumberTFH9100JP
Device Lot NumberN/A
Date Manufacturer Received10/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/08/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
NOT PROVIDED.
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age58 YR
Patient SexFemale
-
-